Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

cAMP is an important messenger for ADP-induced platelet aggregation.

A A Weber1, T Hohlfeld, K Schrör

  • 1Institut für Pharmakologie und Klinische Pharmakologie, Heinrich-Heine-Universität Düsseldorf, Germany.

Platelets
|June 28, 2006
PubMed
Summary

Cyclic adenosine monophosphate (cAMP) may be an important messenger in ADP-induced platelet aggregation, even when cellular cAMP levels do not change. This challenges previous findings and suggests a new role for cAMP in platelet signaling.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of a large dam on reproduction of a non-migratory teleost species, Acestrorhynchus lacustris (Characiformes: Acestrorhynchidae).

Brazilian journal of biology = Revista brasleira de biologia·2021
Same author

[Importance of acetylsalicylic acid in primary prevention : ASCEND, ARRIVE and ASPREE as well as a meta-analysis by Rothwell et al.]

Der Internist·2019
Same author

Platelet function testing: dead or alive.

Journal of thrombosis and haemostasis : JTH·2018
Same author

[Cardiovascular safety of celecoxib : Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen or Naproxen (PRECISION)].

Der Internist·2017
Same author

Dabigatran enhances platelet reactivity and platelet thrombin receptor expression in patients with atrial fibrillation.

Journal of thrombosis and haemostasis : JTH·2016
Same author

Antiplatelet effects of aspirin in chronic kidney disease patients.

Journal of thrombosis and haemostasis : JTH·2015

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Hematology

Background:

  • Previous studies suggested cyclic adenosine monophosphate (cAMP) is not a key messenger in ADP-induced rat platelet aggregation.
  • The role of cAMP in human platelet aggregation, particularly in response to ADP, requires further investigation.

Purpose of the Study:

  • To investigate the effects of prostaglandin E(1) (PGE(1)) and ADP on human platelet aggregation, cAMP generation, and VASP phosphorylation.
  • To determine if changes in cellular cAMP levels are necessary to detect activation or inhibition of the cAMP-protein kinase A (PKA) pathway in platelets.

Main Methods:

  • Studied human platelet aggregation, cAMP generation, and VASP phosphorylation in response to PGE(1) and ADP.
  • Measured VASP phosphorylation, a substrate of PKA, to assess pathway activity.

Related Experiment Videos

Main Results:

  • PGE(1) inhibited platelet aggregation and increased VASP phosphorylation without significant changes in cellular cAMP levels.
  • ADP markedly inhibited basal VASP phosphorylation.
  • These findings indicate that cAMP levels may not accurately reflect cAMP-PKA pathway activity in platelets.

Conclusions:

  • Cyclic adenosine monophosphate (cAMP) determinations may not always detect changes in cAMP-PKA pathway activation or inhibition in platelets.
  • cAMP could be an important second messenger in ADP-induced platelet aggregation, despite the absence of measurable cAMP level changes.